Finance

Lists
SKYE:NASDAQ
Skye Bioscience Inc
USD 1,59
+1,27%
(+0,020) 1D
USD 1,62
+1,74% (+0,028)
Pre-market
Closed: 15 Okt., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SKYE...
Open
USD 1,60
High
USD 1,65
Low
USD 1,55
Mkt. cap
7,04 m
Avg. vol.
69,24 k
Volume
394,00
52-wk high
USD 13,28
52-wk low
USD 1,50
EPS
-USD 10,18
Beta
2,86
Shares outstanding
4,43 m
No. of employees
2
Open
USD 1,60
High
USD 1,65
Low
USD 1,55
Mkt. cap
7,04 m
Avg. vol.
69,24 k
Volume
394,00
52-wk high
USD 13,28
52-wk low
USD 1,50
EPS
-USD 10,18
Beta
2,86
Shares outstanding
4,43 m
No. of employees
2
News stories
From web sources and news partners
About Skye Bioscience Inc
CEO-
Employees2
Founded2011
Headquarters-
Sector-
Websiteskyebioscience.com
Analyst
Recommendation
Action
Price target
Projected
Date
Ananda Ghosh
H.C. Wainwright
Buy
Maintained
USD 20,00
+1 157,9%
05/21/2026
Edward Tenthoff
Piper Sandler
Buy
Reiterated
USD 6,00
+277,4%
05/12/2026
Andy Hsieh
William Blair
Buy
Reiterated
-
-
05/12/2026
Jay Olson
Oppenheimer
Buy
Maintained
USD 10,00
+528,9%
03/11/2026
Kristen Kluska
Cantor Fitzgerald
Hold
Maintained
USD 2,00
+25,8%
03/10/2026
Albert Lowe
Craig-Hallum
Hold
Maintained
-
-
03/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
9,36 m
11,47 m
7,94 m
3,94 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,91 m
3,43 m
4,74 m
3,87 m
Operating expense
13,26 m
14,90 m
12,67 m
7,81 m
Total operating expenses
13,26 m
14,90 m
12,67 m
7,81 m
Operating income
-13,26 m
-14,90 m
-12,67 m
-7,81 m
Other non operating income
-
-502,00
-2,41 k
-
EBT including unusual items
-12,75 m
-14,44 m
-12,51 m
-10,78 m
EBT excluding unusual items
-12,85 m
-14,62 m
-12,51 m
-7,71 m
Income tax expense
-
-
-
3,40 k
Effective tax rate
-
-
-
-0,03%
Other operating expenses
-
-
-
-
Net income
-12,75 m
-14,44 m
-12,51 m
-10,79 m
Net profit margin
-
-
-
-
Earnings per share
-2,59
-2,95
-2,56
-1,55
Interest and investment income
418,47 k
274,10 k
169,62 k
103,21 k
Interest expense
-
-
-2,20 k
-3,30 k
Net interest expenses
418,47 k
274,10 k
167,42 k
99,91 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-13,09 m
-14,72 m
-12,50 m
-7,65 m
Gain or loss from assets sale
-91,40 k
-179,99 k
7,62 k
411,46 k
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme